CJC-1295 10mg
(GHRH)

Premium Grade | UK Supply

(Triacontapeptide – 30 Amino Acids)

Product Overview

CJC-1295 (No DAC), also known as Mod GRF (1–29), is a truncated and structurally modified fragment of endogenous GHRH engineered to improve stability while preserving native receptor selectivity in laboratory research systems. Unlike long acting DAC modified variants, CJC-1295 (No DAC) is designed to exhibit a short biological activity profile, making it particularly relevant for experimental models focused on natural, pulsatile hormone signalling. Researchers investigate this peptide for its predictable molecular structure, rapid receptor engagement, and controlled signalling duration within in-vitro endocrine research frameworks. Manufactured using controlled peptide synthesis and purification methodologies, the premium grade lyophilised format ensures molecular integrity, batch to batch consistency, and compatibility with structured laboratory protocols where precision and repeatability are essential.
(Recommend, Reconstitute with-Acetic Acid)

Scientific Background

From a scientific perspective, CJC-1295 (No DAC) has been widely studied for its interaction with pituitary GHRH receptors and its ability to stimulate pulsatile growth hormone secretion in experimental models. Research literature explores downstream signalling cascades associated with growth hormone release, including interactions with IGF related pathways and endocrine feedback mechanisms. Due to its short-acting profile, CJC-1295 (No DAC) is frequently utilised in studies designed to mirror physiological hormone release patterns, enabling researchers to examine time-dependent signalling behaviour, receptor sensitivity modulation, and endocrine system dynamics under tightly controlled laboratory conditions. Additional investigations assess its stability, receptor affinity, and comparative performance relative to other GHRH analogues within non-clinical research environments.

Research Applications

In laboratory research applications, CJC-1295 (No DAC) is utilised in growth hormone pathway analysis, endocrine signalling studies, receptor activation assays, and comparative peptide behaviour research. It is commonly applied in in-vitro experimental systems examining pulsatile signalling frequency, receptor activation timing, peptide stability, and short duration endocrine response models. Its defined molecular profile and predictable signalling characteristics support high reproducibility in advanced research designs focused on hormone regulation, peptide receptor interaction dynamics, and endocrine system modelling. All applications are strictly confined to non clinical laboratory environments and analytical research contexts.
(Read More About CJC-1295 In Our Article)

Technical Specifications

• Contents: 10mg CJC-1295
• Form: Lyophilized powder
• Purity: >99% (HPLC Verified)
• Molecular Formula: C₁₆₅H₂₆₉N₄₇O₄₆
• Sequence:Tyr‑D‑Ala‑Asp‑Ala‑Ile‑Phe‑Thr‑Gln‑Ser‑Tyr‑Arg‑Lys‑Val‑Leu‑Ala‑Gln‑Leu‑Ser‑Ala Arg‑Lys‑Leu‑Leu‑Gln‑Asp‑Ile‑Leu‑Ser‑Arg‑NH₂
• Peptide Length: 29 Amino‑Acids
• pH Range: 4.5–7.0
• Storage: Store between 2°C and 8°C

Note: Reconstitute with 50% Bacteriostatic (BAC) water and 50% Acetic Acid  for best results.

Related Research Compounds

Sermorelin 10mg
Tesamorelin 10mg
Ipamorelin 10mg

Disclaimer

For research purposes only, Not for human consumption.